跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,958 条关于
“Efsitora Alpha”
全部
3,958
临床试验
1,971
药物
1,093
机构
19
资讯
875
去年
Landmark Clinical Trials of 2024: Advancements in Cancer, Metabolic Diseases, and Infectious Diseases
2年前
Lilly's Once-Weekly Insulin Efsitora Shows Promise in Phase 3 Diabetes Trials
2年前
Eli Lilly's Weekly Insulin Efsitora Shows Promise in Phase 3 Trials
2年前
Eli Lilly's Once-Weekly Insulin Efsitora Demonstrates Non-Inferior Efficacy in Phase 3 Trials for Type 2 Diabetes
2年前
Eli Lilly's Efsitora Alfa Shows Promise in Type 2 Diabetes Treatment
去年
Lilly's Once-Weekly Insulin Efsitora Alfa Achieves Non-Inferiority in Phase 3 Trials, Reducing Injection Burden by 300 Doses Annually
2年前
Eli Lilly's Efsitora Shows Promise in Phase III Trial, Challenging Novo Nordisk's Icodec
去年
Alpha Tau Secures MDSAP Certification for Alpha DaRT Cancer Therapy Manufacturing Facility
去年
Alpha Tau Initiates First U.S. Patient Treatment in Pancreatic Cancer Trial Combining Alpha DaRT with Chemotherapy
3年前
FDA Approves Lamzede for Alpha-Mannosidosis Treatment
第 1 页,共 88 页
上一页
下一页